Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLH | Q9Y253 | 8/20 | 0.72 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.72 |
| ▸ | MEN1 | O00255 | 4/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.72 |
| ▸ | POLB | P06746 | 4/20 | 0.72 |
| ▸ | RECQL | P46063 | 4/20 | 0.72 |
| ▸ | GAA | P10253 | 3/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.72 |
| ▸ | APEX1 | P27695 | 3/20 | 0.72 |
| ▸ | MMP1 | P03956 | 2/20 | 0.72 |
| ▸ | MAPT | P10636 | 2/20 | 0.72 |
| ▸ | BLM | P54132 | 2/20 | 0.72 |
| ▸ | HTT | P42858 | 1/20 | 0.72 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.65 |
| ▸ | SLCO2B1 | O94956 | 3/20 | 0.65 |
| ▸ | AKR1B1 | P15121 | 3/20 | 0.65 |
| ▸ | MAOA | P21397 | 3/20 | 0.65 |
| ▸ | XDH | P47989 | 3/20 | 0.65 |
| ▸ | USP2 | O75604 | 2/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Quercetin SCHEMBL4473370 | 0.96 | MEN1 (0.74) | POLHKDM4EMEN1KMT2APOLB | |
| SCHEMBL119670 | 0.91 | POLH (0.73) | POLHKDM4EMEN1KMT2APOLB | |
| SCHEMBL14786208 | 0.86 | POLH (0.81) | POLHKDM4EMEN1KMT2APOLB | |
| SCHEMBL4286345 | 0.86 | MEN1 (0.65) | POLHKDM4EMEN1KMT2APOLB | |
| SCHEMBL3757805 | 0.85 | POLH (0.74) | POLHKDM4EMEN1KMT2APOLB | |
| SCHEMBL28297226 | 0.85 | POLH (0.79) | POLHKDM4EMEN1KMT2APOLB | |
| SCHEMBL9512509 | 0.84 | POLH (0.77) | POLHKDM4EMEN1KMT2APOLB | |
| 3-O-Methylquercetin SCHEMBL29897544 | 0.84 | POLH (1.00) | POLHKDM4EMEN1KMT2APOLB | |
| 3-O-Methylquercetin SCHEMBL380558 | 0.84 | POLH (1.00) | POLHKDM4EMEN1KMT2APOLB | |
| SCHEMBL2396323 | 0.83 | HSD17B10 (0.66) | POLHKDM4EMEN1KMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118580384-A | Fucoidin Process for producing phosphoric acid esters | 青岛职业技术学院 | 2024-09-03 | — | — | CN | claimed |
| CN-105902487-A | Injection pharmaceutical composition capable of improving stability of quercetin medication injection preparation | 成都易创思生物科技有限公司 | 2016-08-31 | — | — | CN | claimed |
| CN-105241938-A | Construction method and detection method of potassium ion nucleic acid aptamer photoelectrochemical sensor based on diluted magnetic semiconductor | YANCHENG INST TECHNOLOGY | 2016-01-13 | — | — | CN | claimed |
| US-20090325906-A1 | Methods and compositions for therapeutic treatment | LIMERICK BIOPHARMA, INC. | 2009-12-31 | — | — | US | claimed |
| WO-2009158031-A2 | METHODS AND COMPOSITIONS FOR THERAPEUTIC TREATMENT | LIMERICK BIOPHARMA, INC. (US) | 2009-12-30 | — | — | WO | claimed |
| WO-2009158007-A2 | METHODS AND COMPOSITIONS FOR THERAPEUTIC TREATMENT | LIMERICK BIOPHARMA, INC. (US) | 2009-12-30 | — | — | WO | claimed |
| JP-1153695-A | — | — | None | — | — | JP | disclosed |
| CN-118580384-A | Fucoidin Process for producing phosphoric acid esters | 青岛职业技术学院 | 2024-09-03 | — | — | CN | disclosed |
| CN-118580384-A | Fucoidin Process for producing phosphoric acid esters | 青岛职业技术学院 | 2024-09-03 | — | — | CN | disclosed |
| WO-2018172942-A1 | QUERCETIN NANOPARTICLES | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2018-09-27 | — | — | WO | disclosed |
| WO-2018172942-A1 | QUERCETIN NANOPARTICLES | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2018-09-27 | — | — | WO | disclosed |
| CN-105963247-A | Preparation method of injection medicine for improving stability of quercetin medicine injection preparation | 成都易创思生物科技有限公司 | 2016-09-28 | — | — | CN | disclosed |
| CN-105902487-A | Injection pharmaceutical composition capable of improving stability of quercetin medication injection preparation | 成都易创思生物科技有限公司 | 2016-08-31 | — | — | CN | disclosed |
| EP-2182957-A2 | PHOSPHORYLATED PYRONE ANALOGS AND METHODS | Limerick BioPharma, Inc. (US) | 2010-05-12 | — | — | EP | disclosed |
| US-20090325906-A1 | Methods and compositions for therapeutic treatment | LIMERICK BIOPHARMA, INC. | 2009-12-31 | — | — | US | disclosed |
| WO-2009158031-A2 | METHODS AND COMPOSITIONS FOR THERAPEUTIC TREATMENT | LIMERICK BIOPHARMA, INC. (US) | 2009-12-30 | — | — | WO | disclosed |
| WO-2009158007-A2 | METHODS AND COMPOSITIONS FOR THERAPEUTIC TREATMENT | LIMERICK BIOPHARMA, INC. (US) | 2009-12-30 | — | — | WO | disclosed |
| US-20090069273-A1 | PHOSPHORYLATED PYRONE ANALOGS AND METHODS | LIMERICK BIOPHARMA, INC. | 2009-03-12 | — | — | US | disclosed |
| WO-2009018338-A2 | PHOSPHORYLATED PYRONE ANALOGS AND METHODS | LIMERICK BIOPHARMA, INC. (US) | 2009-02-05 | — | — | WO | disclosed |
| JP-H01153695-A | PRODUCTION OF RUTIN OR QUERCETIN PHOSPHORIC ACID ESTER | SHOWA DENKO KK | 1989-06-15 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090069273-A1 | PHOSPHORYLATED PYRONE ANALOGS AND METHODS | PCK1, PC, PCK2 | POLH 2464/4885KDM4E 1623/4885MEN1 4072/4885 |
| US-20090325906-A1 | Methods and compositions for therapeutic treatment | SLC2A1, SLC2A2, SLC2A3 | POLH 3338/4885KDM4E 4285/4885MEN1 4409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.